Nanopublications

Matches in Nanopublications for { ?s ?p "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 100 of ±218 with 100 items per page.

NP924356.RARKCe2vdqz-NZsNyMW49fkFaARy3Z3WzcPfVidEkzEz8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924356.RARKCe2vdqz-NZsNyMW49fkFaARy3Z3WzcPfVidEkzEz8130_provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP49920.RActHJuqIQxsQwgNNFelge3ypP5rS7n0O1BM2jMDXEPyY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49920.RActHJuqIQxsQwgNNFelge3ypP5rS7n0O1BM2jMDXEPyY130_provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP78839.RAR0SfyASK-HugLvCkuy6hMlgSTe9qFKpqNCABR24JRv4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78839.RAR0SfyASK-HugLvCkuy6hMlgSTe9qFKpqNCABR24JRv4130_provenance.
NP78859.RAZ7Ey7D4KqMGf5r5MblAkJbpra_Pon5SXHxqIias4ZYw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78859.RAZ7Ey7D4KqMGf5r5MblAkJbpra_Pon5SXHxqIias4ZYw130_provenance.
NP84752.RAWw0WEZx3Ls3_b5xOjwlHjoiHjdIzjr2NhR-BXo5s1Ko130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84752.RAWw0WEZx3Ls3_b5xOjwlHjoiHjdIzjr2NhR-BXo5s1Ko130_provenance.
NP84764.RAZw3LNYNqkL623kMB0_g33OR-ny1p9DnPbh8SUPWcq9I130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84764.RAZw3LNYNqkL623kMB0_g33OR-ny1p9DnPbh8SUPWcq9I130_provenance.
NP84768.RAeyTd5I2AE9_k96GPHOIlx_8vUirZaJGvjYnoK6ciMYc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84768.RAeyTd5I2AE9_k96GPHOIlx_8vUirZaJGvjYnoK6ciMYc130_provenance.
NP84776.RAQvnrHdFANydpX0KLPj-vtn0hU1Sd8pOWQZ-fhS85mNM130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84776.RAQvnrHdFANydpX0KLPj-vtn0hU1Sd8pOWQZ-fhS85mNM130_provenance.
NP84800.RAQ0jIWuQ0b1hElrABDJM7MsNnK1zdJVBigSKuiDfwHY4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84800.RAQ0jIWuQ0b1hElrABDJM7MsNnK1zdJVBigSKuiDfwHY4130_provenance.
NP86433.RAZ0UvF4G-vq4QiHl7kptlDXJNi4FekIOxcd3Ky4eq0X8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86433.RAZ0UvF4G-vq4QiHl7kptlDXJNi4FekIOxcd3Ky4eq0X8130_provenance.
NP96442.RAf0SSWV6Q97m5nbMag5lIzDvwv-K71dim5oMZPUMT1Zk130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96442.RAf0SSWV6Q97m5nbMag5lIzDvwv-K71dim5oMZPUMT1Zk130_provenance.
NP96716.RAXbH-psZkELOZrfz8lWxk-g2ZMaBDJNP4i2ioukxEIEs130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96716.RAXbH-psZkELOZrfz8lWxk-g2ZMaBDJNP4i2ioukxEIEs130_provenance.
NP96909.RAXxTnbUGqgBRlSCr79Te5zjFpPg2SWwePL0ioT6mfx4U130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96909.RAXxTnbUGqgBRlSCr79Te5zjFpPg2SWwePL0ioT6mfx4U130_provenance.
NP133052.RAQ5SM9t17ECfAif001T5JOQiX-WDIKudTIVuyqrWYDuU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133052.RAQ5SM9t17ECfAif001T5JOQiX-WDIKudTIVuyqrWYDuU130_provenance.
NP133131.RAcQnC6YmLyRyRAGG75g7i3SUaasO3FVMHEcbLWY72ST0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133131.RAcQnC6YmLyRyRAGG75g7i3SUaasO3FVMHEcbLWY72ST0130_provenance.
NP133141.RAeOhfcZoS7KHqZMUGKeKmkit9_GaVX8_rwbxWFbBiRWw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133141.RAeOhfcZoS7KHqZMUGKeKmkit9_GaVX8_rwbxWFbBiRWw130_provenance.
NP133156.RAcXTvp2k8wQye4PTpJO8vH1XX9zHBa8f64eRaoQXrwW8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133156.RAcXTvp2k8wQye4PTpJO8vH1XX9zHBa8f64eRaoQXrwW8130_provenance.
NP133157.RAVJ-Irg5H4d56BdDeoHXcSXOc6TG9qe_l13ZhvdmVLeo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133157.RAVJ-Irg5H4d56BdDeoHXcSXOc6TG9qe_l13ZhvdmVLeo130_provenance.
NP137264.RAY3UrLAkDOBfWSDSkcfTCxS_0j4r2pVf8klYbv8_s-eA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137264.RAY3UrLAkDOBfWSDSkcfTCxS_0j4r2pVf8klYbv8_s-eA130_provenance.
NP146463.RATDYRhfMputVZddLpTSoQsY1xU_rjjihql4S2I_ZqPv0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146463.RATDYRhfMputVZddLpTSoQsY1xU_rjjihql4S2I_ZqPv0130_provenance.
NP146464.RAQs7eXTww_iNIAF6B5r9NI26cTMS46UznmHtdXxknTxg130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146464.RAQs7eXTww_iNIAF6B5r9NI26cTMS46UznmHtdXxknTxg130_provenance.
NP524713.RAWlKaVePAkRG6_wxlWN_Nmnub4fEw3oN0df0Gqq3ZYTc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524713.RAWlKaVePAkRG6_wxlWN_Nmnub4fEw3oN0df0Gqq3ZYTc130_provenance.
NP533058.RAO3kM-cwky_AoB6v5YywwXbAoRuZy1C457vb4-bigBYU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533058.RAO3kM-cwky_AoB6v5YywwXbAoRuZy1C457vb4-bigBYU130_provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP103085.RArwqgm_AMG-EYAREaC0sv-_PhNPXTv3h6BsI6jMWCOn8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103085.RArwqgm_AMG-EYAREaC0sv-_PhNPXTv3h6BsI6jMWCOn8130_provenance.
NP103603.RAtE9oCYieiDKeXPD-AGExefeDN_qFmfk47N3zg_lkJPE130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103603.RAtE9oCYieiDKeXPD-AGExefeDN_qFmfk47N3zg_lkJPE130_provenance.
NP132972.RAn2JyTgOGMxjbxCfsvoNKXuTL4EAAC52H1OvXmWR7OCg130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132972.RAn2JyTgOGMxjbxCfsvoNKXuTL4EAAC52H1OvXmWR7OCg130_provenance.
NP132994.RAk3wD-9VRdqjD_entgHvBoS-wcBGR3N8701nnU9rj82M130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132994.RAk3wD-9VRdqjD_entgHvBoS-wcBGR3N8701nnU9rj82M130_provenance.
NP132995.RAm_h9xPof0jf3XeU6T40L1Svyir2nCwt2Ooav0o8W4cI130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132995.RAm_h9xPof0jf3XeU6T40L1Svyir2nCwt2Ooav0o8W4cI130_provenance.
NP133023.RAuKxJjK789sZDDE4LGVDaydDzXtyjc3Qb4Nljs8MHwmA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133023.RAuKxJjK789sZDDE4LGVDaydDzXtyjc3Qb4Nljs8MHwmA130_provenance.
NP133051.RAsm0W_lYZeMAsiTzrVMegyNWY_PoLtM5fSxnEIqi9RoA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133051.RAsm0W_lYZeMAsiTzrVMegyNWY_PoLtM5fSxnEIqi9RoA130_provenance.
NP133089.RAmUpKBizf7i0VyeANBJfH6xZGYFi_l3JhGhCCgnbst8Q130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133089.RAmUpKBizf7i0VyeANBJfH6xZGYFi_l3JhGhCCgnbst8Q130_provenance.
NP133090.RAl_91DwjsqSFzjYcLyEze1eaJxPCon9z9Wi4Wh1bVExo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133090.RAl_91DwjsqSFzjYcLyEze1eaJxPCon9z9Wi4Wh1bVExo130_provenance.
NP133130.RAk_MP-5hF34I2IbqM21O6fC4fNjoxdKuBzt2Vpj-x-Iw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133130.RAk_MP-5hF34I2IbqM21O6fC4fNjoxdKuBzt2Vpj-x-Iw130_provenance.
NP137041.RAiMccSKserXmpISsuD8OdH3VWaQyaxu2F_uNa-f4veV0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137041.RAiMccSKserXmpISsuD8OdH3VWaQyaxu2F_uNa-f4veV0130_provenance.
NP137169.RAmhdXS5_UeTcmJSfc83FMVGLzKlEQXOGcOjjs5MfDphA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137169.RAmhdXS5_UeTcmJSfc83FMVGLzKlEQXOGcOjjs5MfDphA130_provenance.
NP146431.RAl-R21wVZ87x5N7YzlqNEZZLi4YlAmNWAQpMbwissWmQ130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146431.RAl-R21wVZ87x5N7YzlqNEZZLi4YlAmNWAQpMbwissWmQ130_provenance.
NP117100.RAmlAuuy4MnjngkH6OFuDmlQQ9LAm1mmkCOQyyVFmmd4A130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117100.RAmlAuuy4MnjngkH6OFuDmlQQ9LAm1mmkCOQyyVFmmd4A130_provenance.
NP117177.RAkTMjrX_xUU4meqtOLND9pQQ_uuUOF6iFXUYTLgCMLJ8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117177.RAkTMjrX_xUU4meqtOLND9pQQ_uuUOF6iFXUYTLgCMLJ8130_provenance.
assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP165028.RASvwwnEx03Q4ImkgkWqj-3zFL8oVzCAzBfNwllrLXKXo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165028.RASvwwnEx03Q4ImkgkWqj-3zFL8oVzCAzBfNwllrLXKXo130_provenance.
NP165042.RAQGZoWCKB-O_Uq-K1n0E2FVavN1uyIXlVX_HbBtVdrys130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165042.RAQGZoWCKB-O_Uq-K1n0E2FVavN1uyIXlVX_HbBtVdrys130_provenance.
NP165044.RAeDsNcQTK_nrUa1dJWTFuwxfkSqmuXW_zp6IHNFEnoLo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165044.RAeDsNcQTK_nrUa1dJWTFuwxfkSqmuXW_zp6IHNFEnoLo130_provenance.
NP165045.RAc63d4IhnJgTDzqnAcqPDfXP74j3qJvNTE075jaNQAGs130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165045.RAc63d4IhnJgTDzqnAcqPDfXP74j3qJvNTE075jaNQAGs130_provenance.